Upstream Bio, Inc. UPB Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Upstream Bio, Inc.'s accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Upstream Bio, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Upstream Bio, Inc. (UPB) reported accretion (amortization) of discounts and premiums, investments of $754K in Q1 2026.
- How has Upstream Bio, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Upstream Bio, Inc.'s accretion (amortization) of discounts and premiums, investments decreased by 56.5% year-over-year, from $1.74M to $754K.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This represents the non-cash adjustment to interest income or expense arising from the amortization of premiums or the accretion of discounts on debt or investment securities. It aligns the carrying value of financial assets or liabilities with their face value over the holding period. This adjustment is essential for reconciling net income to cash flow from operations by removing non-cash yield components.